Lipoglycopeptide Antibacterial [EPC]

Known as: Lipoglycopeptide Antibacterial 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2015
01220072015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The lipopeptides ramoplanin from Actinoplanes sp. ATCC 33076 and enduracidin produced by Streptomyces fungicidicus are effective… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2015
Review
2015
The emergence of resistance to glycopeptide antibiotics such as vancomycin and teicoplanin among Gram-positive bacteria has… (More)
  • figure 1
  • figure 2
  • table 1
  • table 1
  • table 2
Is this relevant?
Review
2013
Review
2013
Natural glycopeptide antibiotics like vancomycin and teicoplanin have played a significant role in countering the threat posed by… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2013
2013
Telavancin is a novel semisynthetic lipoglycopeptide derivative of vancomycin with a dual mode of action. This study sought to… (More)
Is this relevant?
Review
2007
Review
2007
Dalbavancin is a semisynthetic lipoglycopeptide that is derived from teicoplanin with an extended half-life that enables once… (More)
Is this relevant?